Your browser doesn't support javascript.
loading
What the HEC? Clinician Adherence to Evidence-Based Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy.
Roeland, Eric J; Ruddy, Kathryn J; LeBlanc, Thomas W; Nipp, Ryan D; Binder, Gary; Sebastiani, Silvia; Potluri, Ravi; Schmerold, Luke; Papademetriou, Eros; Schwartzberg, Lee; Navari, Rudolph M.
  • Roeland EJ; 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Ruddy KJ; 2Mayo Clinic, Rochester Minnesota.
  • LeBlanc TW; 3Duke University, Durham, North Carolina.
  • Nipp RD; 1Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
  • Binder G; 4Helsinn Therapeutics US, Iselin, New Jersey.
  • Sebastiani S; 5Helsinn Therapeutics, Lugano, Switzerland.
  • Potluri R; 6SmartAnalyst, New York, New York.
  • Schmerold L; 6SmartAnalyst, New York, New York.
  • Papademetriou E; 6SmartAnalyst, New York, New York.
  • Schwartzberg L; 7West Cancer Center, Memphis, Tennessee; and.
  • Navari RM; 8University of Alabama at Birmingham, Birmingham, Alabama.
J Natl Compr Canc Netw ; 18(6): 676-681, 2020 06.
Article en En | MEDLINE | ID: mdl-32502985
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vómitos / Adhesión a Directriz / Antieméticos / Náusea Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vómitos / Adhesión a Directriz / Antieméticos / Náusea Tipo de estudio: Guideline / Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article